| Particulars |
|
|
|
| Company Name
| Alivus Life Sciences Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
24.54 |
B.V. (₹) |
245.80 |
| Sales(₹ Cr.) |
2,386.88 |
NP (₹ Cr.) |
481.33 |
| NP Var (%) |
2.00 |
Div% |
250.00 |
| CPS(₹) |
44.20 |
EPS (₹) |
39.20 |
| Traded Value(₹ Lakhs) |
4,485.69 |
52 Week High |
1,260.00 |
| 52 Week Low |
827.00 |
Price BSE |
896.00 |
| Price NSE |
899.00 |
Market Capital (₹ Cr.) |
10,995.32 |
| P/C Ratio |
20.30 |
P/E Ratio |
22.80 |
| Price Vs.BV |
3.65 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
587.98 |
| NP(₹ Cr.) |
130.03 |
NP Var % |
36.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
2,204.90 |
| OPM |
27.57 |
NP |
423.50 |
| NP Var (%) |
25.24 |
EPS |
43.23 |
| PE |
20.73 |
|
|